3 February 2015
Biofortuna Ltd closes a £1.5m funding round
Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze dried diagnostics and contract services, announces raising £1.5m in its latest funding round. The £1.5m funding was supported by all the company’s current...

20 January 2015
Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim
Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to an Oncology Target … OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has...

13 January 2015
Antitope, INSERM and Baylor Institute to collaborate to produce manufacturing cell lines for two novel vaccines for HIV
Cambridge, UK – Antitope Limited (“Antitope”), an Abzena company (AIM: ABZA) that provides services and technologies to enable the development of better biopharmaceuticals, announces that it has extended its relationship with INSERM, the French National...

3 December 2014
Comply Serve wins at Construction Computing Awards
Comply Serve is thrilled to announce that our progressive assurance software, ComplyPro, has won the Cloud Based Technology Of The Year category at the Construction Computing awards. Impressively Comply Serve was a runner up in two other categories: Infrastructure Project Of The...

26 November 2014
OBT and Menarini announce start of first-in-human clinical study to treat acute myeloid leukemia
$1 Billion Oncology Alliance between Menarini Group & Oxford BioTherapeutics Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia … OXFORD, UK and BERLIN, GERMANY– 25 November 2014 – Oxford BioTherapeutics and Berlin Chemie...

20 November 2014
Amanda Westwood, CEO of Silver Lining Solutions, gives small business tips in This is Money magazine
SMALL BUSINESS ESSENTIALS: How to bag a contract with the big boys and other secrets to landing game-changing deals - by Amanda Westwood, CEO, Silver Lining Solutions … If you're a small business, or self-employed, it might be difficult to imagine landing a contract with some of...

11 November 2014
Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model.
Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model. Read the full article here: http://www.cambridge-news.co.uk/Biotech-big-time-Abzena-s-riding-high/story-24099284-detail/story.html

23 October 2014
Brandhouse wins Top Industry Design Award
Brandhouse, part of Hangar Seven the content creation agency, has picked up two design awards at the Starpack Industry Awards, winning Gold in the 'Food and Drink Primary Packaging' and Best in Show 'Packaging Superstar', for its work on category leader Robinsons SQUASH'D. The...

14 October 2014
Hangar Seven acquires Strategic Video Content Specialists, Media Ark
Leading content creation company, Hangar Seven, today announces the acquisition of Media Ark Limited, specialist creators of video content for retail and consumer brands. Established in 2007 by Matt Carroll, a prolific travel journalist, and Julian Hanton, an experienced TV...

14 October 2014
Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis
Orpington, UK, 8th October 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces the launch of a new improved version of its innovative VivoSight OCT scanner at the...